Puma Biotechnology, Inc. (PBYI)

NasdaqGS • Currently down 1.52 (-15.56%) in today's trading session

1 member of Congress has disclosed 4 trades in Puma Biotechnology, Inc. (PBYI) via STOCK Act filings. The most recent disclosure was a sale by Donna E. Shalala on 15 May 2019. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Puma Biotechnology, Inc. is currently trading at $8.25, positioned at 53% of its 52-week range ($4.58 – $11.50).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$8.25
24h Change
-1.52 (-15.56%)
52 Week Range
$4.58–$11.50
View on NASDAQ

Puma Biotechnology, Inc. Price History and Technical Analysis

Congressional Trading Activity for PBYI

Select to highlight on chart
4 transactions
Compliance: 50%
Donna E. Shalala15 May 201927 Apr 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala15 May 201921 Jul 2020SaleStock$1,001 - $15,000N/A
Donna E. Shalala23 Jan 201927 Apr 2020PurchaseStock$1,001 - $15,000N/A
Donna E. Shalala23 Jan 201921 Jul 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

No overview data available for this stock

Earnings

Next Report

Q4 2026

25 Feb

EPS Est.

$0.23

Rev. Est.

$67.2M

Days Until

108

Recent Quarters

Q3 20265 Nov
EPS$0.15
Beat 66.7%
Q2 20266 Aug
EPS$0.19
Beat 375.0%
Q1 20267 May
EPS$-0.04
Beat 69.2%
Q4 202526 Feb
EPS$0.29
Beat 20.8%
Q3 20256 Nov
EPS$0.21
Beat 133.3%
Q2 20257 Aug
EPS$0.15
Beat 36.4%
Q1 20258 May
EPS$0.10
Beat 400.0%
Q4 202427 Feb
EPS$0.43
Beat 330.0%
Q3 20247 Nov
EPS$0.41
Beat 17.1%
Q2 20241 Aug
EPS$-0.05
Beat 50.0%
Q1 20242 May
EPS$-0.05
Beat 76.9%
Q4 202329 Feb
EPS$0.26
Miss 13.3%
Q3 20232 Nov
EPS$0.12
Beat 50.0%
Q2 20233 Aug
EPS$0.05
Beat 400.0%
Q1 20234 May
EPS$0.03
Beat 140.0%
Q4 20222 Mar
EPS$-0.12
Miss 300.0%
Q3 20223 Nov
EPS$-0.01
Beat 86.3%
Q2 20224 Aug
EPS$0.21
Beat 950.0%
Q1 20225 May
EPS$-0.08
Beat 52.9%
Q4 20213 Mar
EPS$0.10
Beat 211.1%
Q3 20214 Nov
EPS$-1.09
Miss 251.6%
Q2 20215 Aug
EPS$-0.13
Beat 51.9%
Q1 20216 May
EPS$0.40
Beat 344.4%
Q4 202025 Feb
EPS$-0.38
Miss 22.6%
Q3 20205 Nov
EPS$-0.79
Miss 102.6%
Q2 20206 Aug
EPS$0.08
Beat 126.7%
Q1 20207 May
EPS$-0.43
Beat 44.2%
Q4 201920 Feb
EPS$-0.29
Beat 39.6%
Q3 20196 Nov
EPS$-0.44
Beat 38.0%
Q2 20198 Aug
EPS$-0.97
Miss 2.1%
Q1 20199 May
EPS$-0.26
Beat 61.8%
Q4 201828 Feb
EPS$-0.80
Miss 3.9%
Q3 20181 Nov
EPS$-0.37
Beat 61.9%
Q2 20189 Aug
EPS$-1.17
Beat 7.1%
Q1 20189 May
EPS$-0.65
Beat 13.3%
Q4 20171 Mar
EPS$-1.71
Beat 13.6%
Q3 20179 Nov
EPS$-2.07
Beat 24.7%
Q2 20179 Aug
EPS$-2.10
Beat 0.0%
Q1 201710 May
EPS$-1.97
Beat 0.5%
Q4 20161 Mar
EPS$-2.04
Miss 1.0%
Q3 20169 Nov
EPS$-2.02
Miss 1.0%
Q2 20169 Aug
EPS$-2.05
Beat 6.8%
Q1 201610 May
EPS$-2.19
Miss 17.7%
Q4 201529 Feb
EPS$-1.90
Miss 15.8%
Q3 20159 Nov
EPS$-1.87
Miss 23.8%
Q2 201510 Aug
EPS$-2.01
Miss 27.2%
Q1 201511 May
EPS$-1.66
Miss 32.8%
Q4 20142 Mar
EPS$-1.57
Miss 36.5%
Q3 201410 Nov
EPS$-1.19
Beat 6.3%
Q2 201411 Aug
EPS$-1.29
Miss 95.5%
Q1 201412 May
EPS$-0.67
Miss 28.9%
Q4 20133 Mar
EPS$-0.56
Miss 14.3%
Q3 201312 Nov
EPS$-0.50
Miss 8.7%
Q2 20136 Aug
EPS$-0.44
Miss 2.3%
Q1 20139 May
EPS$-0.41
Beat 34.9%
Q1 20131 Apr
EPS$-0.25
Beat 69.1%
Q3 201214 Nov
EPS$-1.29
Miss 148.1%
Q2 201214 Aug
EPS$-0.22
Beat 37.1%
Q1 201215 May
EPS$-0.59
Q4 201129 Mar
EPS$-0.51
Miss 104.0%
Q3 201114 Nov
EPS$-0.00
Q2 201115 Aug
EPS$-0.00
Q1 201116 May
EPS$-0.00
Q4 201030 Mar
EPS$-0.00
Q3 20105 Nov
EPS$-0.00
Q2 201010 Aug
EPS$-0.00
Q1 201014 May
EPS$-0.00
Q4 200930 Mar
EPS$-0.00
Q3 200916 Nov
EPS$-0.00
Q2 200911 Aug
EPS$-0.00
Q1 200915 May
EPS$-0.00
Q4 200830 Mar
EPS$-0.00
Q3 200812 Nov
EPS$-0.00
Q2 20087 Aug
EPS$-0.00
Q1 200815 May
EPS$-0.00
Q4 200731 Mar
EPS$-5.03

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about PBYI

Which members of Congress have traded PBYI?
1 member of Congress has disclosed 4 trade in Puma Biotechnology, Inc. (PBYI) under the STOCK Act: Donna E. Shalala.
When was PBYI most recently disclosed by Congress?
The most recent PBYI disclosure was a sale by Donna E. Shalala on 15 May 2019.
What is the total disclosed congressional trading volume for PBYI?
Members of Congress have disclosed approximately $16K in PBYI purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in PBYI?
This PBYI page updates as soon as new STOCK Act disclosures are filed for Puma Biotechnology, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.